Ticker Details
Oric Pharmaceuticals, Inc.
IPO Date:	April 24, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$861.27M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.46 | 3.60%
Avg Daily Range (30 D):	$0.20 | 2.15%
Avg Daily Range (90 D):	$0.37 | 3.55%

Institutional Daily Volume
Avg Daily Volume:	.5M
Avg Daily Volume (30 D):	1.12M
Avg Daily Volume (90 D):	1.53M

Trade Size
Avg Trade Size (Sh.):	86
Avg Trade Size (Sh.) (30 D):	74
Avg Trade Size (Sh.) (90 D):	89

Institutional Trades
Total Institutional Trades:	1,174
Avg Institutional Trade:	$1.66M
Avg Institutional Trade (30 D):	$1.39M
Avg Institutional Trade (90 D):	$2.01M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.87M
Avg Closing Trade (30 D):	$1.78M
Avg Closing Trade (90 D):	$2.37M
Avg Closing Volume:	163.61K

News

May 12, 2026 @ 9:41 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Apr 3, 2026 @ 8:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Oric Pharmaceuticals, Inc.

Apr 1, 2026 @ 6:48 AM ORIC Pharmaceuticals Stock Nosedives 25% After Hou... Source: Tanya Rawat

Jan 14, 2026 @ 3:52 PM Precision Killers: Why Big Pharma is Betting Billi... Source: Prnewswire

Dec 6, 2025 @ 1:00 AM ORIC® Pharmaceuticals Presents Potential Best-i... Source: Oric Pharmaceuticals

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.41	$-.34	$-.27
Diluted EPS	$-1.41	$-.34	$-.27
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-135.21M	$-35.77M	$-30.51M
Operating Income / Loss	$-149.91M	$-39.62M	$-34.55M
Cost of Revenue
Net Cash Flow	$7.06M	$10.73M	$-4M
PE Ratio